BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6577950)

  • 1. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.
    Berdel WE; Fromm M; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
    Cancer Res; 1983 Nov; 43(11):5538-43. PubMed ID: 6577950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias.
    Berdel WE; Schick HD; Fink U; Reichert A; Ulm K; Rastetter J
    Cancer Res; 1985 Mar; 45(3):1206-13. PubMed ID: 3971369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
    Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
    Fromm M; Berdel WE; Schick HD; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
    Lipids; 1987 Nov; 22(11):916-8. PubMed ID: 3444385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid.
    Andreesen R; Munder PG
    J Natl Cancer Inst; 1983 Apr; 70(4):623-7. PubMed ID: 6300501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
    Long RC; Small WC; Brynes RK; Tidwell T; Goldstein JH; Vogler WR
    Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Oepke GH; Common H; Löhr GW; Munder PG
    Anticancer Res; 1982; 2(1-2):95-100. PubMed ID: 7114806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective destruction of human leukemic cells by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Weltzien HU; Eibl H; Common HH; Löhr GW; Munder PG
    Cancer Res; 1978 Nov; 38(11 Pt 1):3894-9. PubMed ID: 279399
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia.
    Juvekar AS; Chitnis MP; Adwankar MK; Advani SH
    Neoplasma; 1986; 33(4):477-82. PubMed ID: 3463880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells.
    Berdel WE; Greiner E; Fink U; Zänker KS; Stavrou D; Trappe A; Fahlbusch R; Reichert A; Rastetter J
    Oncology; 1984; 41(2):140-5. PubMed ID: 6709277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.
    Modolell M; Andreesen R; Pahlke W; Brugger U; Munder PG
    Cancer Res; 1979 Nov; 39(11):4681-6. PubMed ID: 498095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivatives of benzo(c)fluorene. XXIV. Cytostatic effect of benfluron on human leukemic cells in vitro.
    Soucek J; Stöckbauer P; Mĕlka M; Koubek K; Chudomel V; Krepelka J
    Neoplasma; 1987; 34(1):45-54. PubMed ID: 3561605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
    Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
    Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368).
    Andreesen R; Modolell M; Oepke GH; Munder PG
    Exp Hematol; 1983 Jul; 11(6):564-70. PubMed ID: 6617791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effect of O-alkyl lysophospholipids on the growth of a human lung giant cell carcinoma cell line.
    Goto I; Hozumi M; Honma Y
    Anticancer Res; 1994; 14(2A):357-62. PubMed ID: 8017834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor action of alkyl-lysophospholipids (Review).
    Berdel WE; Bausert WR; Fink U; Rastetter J; Munder PG
    Anticancer Res; 1981; 1(6):345-52. PubMed ID: 7046622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
    Vogler WR; Whigham EA; Somberg LB; Long RC; Winton EF
    Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
    Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
    Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
    Dulisch I; Neumann HA; Löhr GW; Andreesen R
    Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.